CellaVision AB (publ)
CLVSF · OTC
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Market Cap | $4,323,169 | $4,338,966 | $4,614,765 | $6,836,616 |
| - Cash | $158,668 | $155,281 | $182,317 | $149,430 |
| + Debt | $27,258 | $30,158 | $22,957 | $26,849 |
| Enterprise Value | $4,191,759 | $4,213,843 | $4,455,405 | $6,714,035 |
| Revenue | $175,633 | $191,328 | $194,802 | $186,688 |
| % Growth | -8.2% | -1.8% | 4.3% | – |
| Gross Profit | $121,301 | $129,572 | $137,209 | $129,171 |
| % Margin | 69.1% | 67.7% | 70.4% | 69.2% |
| EBITDA | $39,621 | $52,134 | $57,728 | $63,819 |
| % Margin | 22.6% | 27.2% | 29.6% | 34.2% |
| Net Income | $31,338 | $37,610 | $41,517 | $40,940 |
| % Margin | 17.8% | 19.7% | 21.3% | 21.9% |
| EPS Diluted | 1.31 | 1.58 | 1.74 | 1.72 |
| % Growth | -17.1% | -9.2% | 1.2% | – |
| Operating Cash Flow | $29,626 | $58,052 | $61,426 | $45,993 |
| Capital Expenditures | -$22,200 | -$24,819 | -$21,384 | -$25,123 |
| Free Cash Flow | $7,426 | $33,233 | $40,042 | $20,870 |